A carregar...

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age

BACKGROUND: The Women’s Health Initiative (WHI) randomized trials found that use of combined estrogen and progestin menopausal hormone therapy (CHT) increases breast cancer risk, but use of unopposed estrogen hormone therapy (EHT) does not. However, several questions regarding the impact of hormone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Christopher I., Daling, Janet R., Haugen, Kara L., Tang, Mei Tzu Chen, Porter, Peggy L., Malone, Kathleen E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075765/
https://ncbi.nlm.nih.gov/pubmed/24748570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2960-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!